The results of early physiotherapy on a child with incontinentia pigmenti with encephalocele

BMJ Case Reports

Volumn , Issue , 2010, Pages

  Kara, Ozgun Kaya ^a   Mutlu, Akmer ^a   Gunel, Mintaze Kerem ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897871634     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.03.2010.2814     Document Type: Article

References (41)

1. Garrod AE. Peculiar pigmentation of the skin of an infant. Trans Clin Soc Lond 1906;39:216. Search Google Scholar
2. Shah SN, Gibbs S, Upton CJ, et al. Incontinentia pigmenti associated with cerebral palsy and cerebral leukomalacia: a case report and literature review. Pediatr Dermatol 2003;20:491-4. [CrossRef] [Medline] [Web of Science] (Pubitemid 38021312)
3. Kim BJ, Shin HS, Won CH, et al. Incontinentia pigmenti: clinical observation of 40 Korean cases. J Korean Med Sci 2006;21:474-7. [CrossRef] [Medline] [Web of Science]
4. Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol 2002;47:169-87. [CrossRef] [Medline] [Web of Science]
5. Cohen BA. Incontinentia pigmenti. Neurol Clin 1987;5:361-77. [Medline] [Web of Science] (Pubitemid 17148947)
6. Shastry BS. Recent progress in the genetics of incontinentia pigmenti (Bloch-Sulzberger syndrome). J Hum Genet 2000;45:323-6. [CrossRef] [Medline]
7. Oranje AP, Arts WF, Wagner A, et al. [From gene to disease; incontinentia pigmenti and the NEMO-gene]. Ned Tijdschr Geneeskd 2005;149:1682-5. [Medline]
8. Sefiani A, Abel L, Heuertz S, et al. The gene for incontinentia pigmenti is assigned to Xq28. Genomics 1989;4:427-9. [CrossRef] [Medline] [Web of Science]
9. Carney RG. Incontinentia pigmenti. A world statistical analysis. Arch Dermatol 1976;112:535-42. [CrossRef] [Medline] [Web of Science]
10. Welbury TA, Welbury RR. Incontinentia pigmenti (Bloch-Sulzberger syndrome): report of case. ASDC J Dent Child 1999;66:213-5, 155. [Medline]
11. Yamashiro T, Nakagawa K, Takada K. Case report: orthodontic treatment of dental problems in incontinentia pigmenti. Angle Orthod 1998;68:281-4. [Medline] (Pubitemid 128543195)
12. Lee AG, Goldberg MF, Gillard JH, et al. Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging, angiography, and spectroscopic imaging. Arch Pediatr Adolesc Med 1995;149:573-80. [CrossRef] [Medline] [Web of Science]
13. Miteva L, Nikolova A. Incontinentia pigmenti: a case associated with cardiovascular anomalies. Pediatr Dermatol 2001;18:54-6. [CrossRef] [Medline] (Pubitemid 32163915)
14. Cohen PR. Incontinentia pigmenti: clinicopathologic characteristics and differential diagnosis. Cutis 1994;54:161-6. [Medline] [Web of Science] (Pubitemid 24280246)
15. Ardelean D, Pope E. Incontinentia pigmenti in boys: a series and review of the literature. Pediatr Dermatol 2006;23:523-7. [CrossRef] [Medline] [Web of Science] (Pubitemid 44800267)
16. Chan YC, Giam C. A retrospective study of incontinentia pigmenti seen at the National Skin Center, Singapore over a 10-year period. Ann Acad Med Singapore 2001;6:1210-17. Search Google Scholar
17. Buinauskiene J, Buinauskaite E, Valiukeviciene S. Incontinentia pigmenti (Bloch-Sulzberger syndrome) in neonates. Medicina (Kaunas) 2005;41:496-9. [Medline]
18. Sahn EE, Davidson LS. Incontinentia pigmenti: three cases with unusual features. J Am Acad Dermatol 1994;31(5 Pt 2):852-7. [CrossRef] [Medline] (Pubitemid 24336180)
19. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet 1993;30:53-9. [FREE Full text] (Pubitemid 23067559)
20. Domínguez-Reyes A, Aznar-Martin T, Cabrera-Suarea E. General and dental characteristics of Bloch-Sulzberger syndrome. Review of literature and presentation of a case report. Med Oral 2002;7:293-7. [Medline]
21. García-Dorado J, de Unamuno P, Fernández-López E, et al. Incontinentia pigmenti: XXY male with a family history. Clin Genet 1990;38:128-38. [Medline] [Web of Science] (Pubitemid 20208850)
22. Vicente-Villa A, Lamas JV, Pascual AM, et al. Incontinentia pigmenti: a report of ten cases. Eur J Pediatr 2001;160:64-5. [CrossRef] [Medline] (Pubitemid 32060075)
23. Girolami GL, Campbell SK. Efficacy of a neurodevelopmental treatment to improve motor control in infants born prematurely. Pediatric Physical Therapy 1994;6:175-84. Search Google Scholar
24. Bayley N. Bayley Scales of infant development-II. San Antonio, Texas, USA: The Psychological Corporation, 1993. Search Google Scholar
25. Bayley N. Bayley Scales of infant and toddler development. 3rd edn. San Antonio, Texas, USA: Harcourt Assessment, 2005. Search Google Scholar
26. Enkelaar L, Ketelaar M, Gorter JW. Association between motor and mental functioning in toddlers with cerebral palsy. Dev Neurorehabil 2008;11:276-82. [CrossRef] [Medline]
27. Palisano RJ, Cameron D, Rosenbaum PL, et al. Stability of the gross motor function classification system. Dev Med Child Neurol 2006;48:424-8. [CrossRef] [Medline] [Web of Science] (Pubitemid 43740901)
28. Russell DJ, Avery LM, Rosenbaum PL, et al. Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity. Phys Ther 2000;80:873-85. [Abstract/FREE Full text]
29. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7. [Abstract/FREE Full text] (Pubitemid 17026064)
30. Johnson DA, Rivlin E, Stein DG. Paediatric rehabilitation: improving recovery and outcome in childhood disorders. Pediatr Rehabil 2001;4:1-3. [Medline] (Pubitemid 32303482)
31. Catalano RA. Incontinentia pigmenti. Am J Ophthalmol 1990;110:679-700. Search Google Scholar
32. Hennel SJ, Ekert PG, Volpe JJ, et al. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr Neurol 2003;29:148-50. [CrossRef] [Medline] [Web of Science] (Pubitemid 37324388)
33. Ruiz-Maldonado R, Toussaint S, Tamayo L, et al. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol 1992;9:1-10. [Medline] [Web of Science]
34. Pascual-Castroviejo I, López-Rodriguez L, de la Cruz Medina M, et al. Hypomelanosis of Ito. Neurological complications in 34 cases. Can J Neurol Sci 1988;15:124-9. [Medline] [Web of Science]
35. Beckung E, Steffenburg U, Uvebrant P. Motor and sensory dysfunctions in children with mental retardation and epilepsy. Seizure 1997;6:43-50. [CrossRef] [Medline] (Pubitemid 27102057)
36. Forssberg HA, Hirschfeld H Forssberg HA. Neural control model for human locomotion development: implications for therapy. In: Forssberg HA, Hirschfeld H, eds. Movement disorders in children. Basel, Med Sport Sci, Karger, 1992:174-81. Search Google Scholar
37. Aylward GP. Cognitive and neuropsychological outcomes: more than IQ scores. Ment Retard Dev Disabil Res Rev 2002;8:234-40. [CrossRef] [Medline] [Web of Science] (Pubitemid 35453794)
38. Gauthier SM, Bauer CR, Messinger DS, et al. The Bayley Scales of Infant Development. II: Where to start? J Dev Behav Pediatr 1999;20:75-9. [Medline] [Web of Science]
39. Yigit S, Kerem M, Livanelioglu A, et al. Early physiotherapy intervention in premature infants. Turk J Pediatr 2002;44:224-9. [Medline]
40. Baryy MJ. Physical therapy interventions for patients with movement disorders due to cerebral palsy. J Child Neurology 1996;11:51-60. Search Google Scholar
41. Ottenbacher KJ, Biocca Z, DeCremer G, et al. Quantitative analysis of the effectiveness of pediatric therapy. Emphasis on the neurodevelopmental treatment approach. Phys Ther 1986;66:1095-101. [Abstract/FREE Full text] (Pubitemid 16094246)